On Monday, Nuvation Bio Inc (NYSE: NUVB) opened lower -7.61% from the last session, before settling in for the closing price of $1.97. Price fluctuations for NUVB have ranged from $1.67 to $4.16 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -499.43% at the time writing. With a float of $226.09 million, this company’s outstanding shares have now reached $335.25 million.
In an organization with 51 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -32.69%, operating margin of -5541.88%, and the pretax margin is -21940.68%.
Nuvation Bio Inc (NUVB) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Nuvation Bio Inc is 33.02%, while institutional ownership is 45.92%. The most recent insider transaction that took place on Nov 11 ’24, was worth 162,883. In this transaction CEO, ANHEART THERAPEUTICS LTD. of this company sold 56,361 shares at a rate of $2.89, taking the stock ownership to the 3,866,228 shares. Before that another transaction happened on Oct 08 ’24, when Company’s Director bought 100,000 for $2.20, making the entire transaction worth $220,000. This insider now owns 100,000 shares in total.
Nuvation Bio Inc (NUVB) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -499.43% per share during the next fiscal year.
Nuvation Bio Inc (NYSE: NUVB) Trading Performance Indicators
Check out the current performance indicators for Nuvation Bio Inc (NUVB). In the past quarter, the stock posted a quick ratio of 9.57. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 284.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.17, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Nuvation Bio Inc (NUVB)
Let’s dig in a bit further. During the last 5-days, its volume was 2.85 million. That was better than the volume of 2.41 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 7.49%. Additionally, its Average True Range was 0.16.
During the past 100 days, Nuvation Bio Inc’s (NUVB) raw stochastic average was set at 1.21%, which indicates a significant decrease from 3.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.79% in the past 14 days, which was lower than the 71.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.4850, while its 200-day Moving Average is $2.7705. However, in the short run, Nuvation Bio Inc’s stock first resistance to watch stands at $2.0733. Second resistance stands at $2.3267. The third major resistance level sits at $2.4633. If the price goes on to break the first support level at $1.6833, it is likely to go to the next support level at $1.5467. Assuming the price breaks the second support level, the third support level stands at $1.2933.
Nuvation Bio Inc (NYSE: NUVB) Key Stats
There are currently 336,567K shares outstanding in the company with a market cap of 614.37 million. Presently, the company’s annual sales total 0 K according to its annual income of -75,800 K. Last quarter, the company’s sales amounted to 730 K and its income totaled -41,210 K.
